rheumatoid%20arthritis
RHEUMATOID ARTHRITIS

Rheumatoid arthritis is a systemic autoimmune rheumatic disorder of unknown etiology.
It is the most common form of inflammatory arthritis.
Patient usually complains of joint pain and/or swelling with morning stiffness that lasts for more than an hour.

Goals of treatment are clinical & radiological remission of disease and to reduce functional limitations & permanent joint damage.

Introduction

  • A chronic inflammatory arthritis of unknown etiology
    • Most common autoimmune inflammatory arthritis in adults
    • Persistent synovitis leads to joint destruction & deformity

Signs and Symptoms

General
  • Joint pain &/or swelling
  • Morning stiffness lasting >1 hour
  • Myalgia, fatigue, weight loss, low-grade fever, depression
  • Typically involves the joints of the fingers, wrists, toes
    • Upper & lower extremity joints are also affected (eg shoulders, elbows, knees & ankles)
  • Syndrome of polymyalgia rheumatica may occasionally be present

Early Rheumatoid Arthritis

  • Duration of occurrence of rheumatoid arthritis signs & symptoms is <6 months

Established Rheumatoid Arthritis

  • Duration of occurrence of rheumatoid arthritis signs & symptoms is ≥6 months & meets the classification criteria of rheumatoid arthritis

Palindromic Rheumatism

  • Follows an episodic pattern
    • Joints may be affected for hours to days followed by symptom-free periods lasting for days to month

Monoarthritis

  • May indicate onset of a polyarticular disease
    • Interval between monoarthritis & polyarthritis may extend from days to weeks in patients with progressive disease
  • Large joints are frequently affected (eg shoulder, wrist, hip, knee, ankles)
  • History of joint trauma may be the initiating event

Extra-articular Involvement

  • Anemia, fatigue, pleuropericarditis, neuropathy, scleritis, Sjogren’s syndrome, vasculitis
  • Subcutaneous rheumatoid nodules on extensor surfaces of elbows & over Achilles tendons
  • Splenomegaly, renal disease
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Elvira Manzano, 17 Oct 2017
Bisphosphonates have proven antifracture efficacy and remain to be the cornerstone of osteoporosis treatment. However, a drug holiday is of particular importance with bisphosphonates due to some signals with long-term use of the drug, including rare incidence of atypical femoral fracture (AFF) and osteonecrosis of the jaw (ONJ), says a leading endocrinologist at AFOS 2017.
Kavitha G. Shekar, 14 Jun 2016
The incidence of type 1 diabetes mellitus (T1D) was found to be higher in juvenile idiopathic arthritis patients (JIA) compared with the general population, said German researchers at the European League Against Rheumatism Annual Congress (EULAR 2016) held in London, UK.
Elaine Tan, 29 Jun 2017

Tofacitinib, a first-in-class Janus kinase (JAK) inhibitor, shows promise as an oral treatment with quick onset of action and sustained efficacy in patients with psoriatic arthritis (PsA) who do not respond adequately to conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs). 

Dr. Priscilla Wong, Dr. Lydia Tam, Prof. LS Tam, 10 Nov 2017
This case report highlights that psoriatic arthritis is a heterogenous disease affecting multiple disease domains, and effective treatment requires thorough assessment of each of these different domains.